Application of povidone-iodine at delivery significantly increases maternal urinary iodine but not neonatal thyrotropin in an area with iodine sufficiency

J Pediatr Endocrinol Metab. 2017 Aug 28;30(9):967-972. doi: 10.1515/jpem-2017-0087.

Abstract

Background: The aim of the present study was to investigate the effect of povidone-iodine (PVP-I) application at delivery on maternal urinary iodine concentration (UIC) and neonatal thyrotropin concentration.

Methods: In this cross-sectional study, urine samples were collected from each pregnant woman after admission to the hospital and before routine application of the PVP-I for delivery preparation and after delivery at time of screening for congenital hypothyroidism. A heel-prick blood sample was taken from all newborns.

Results: A total of 394 pregnant women at time of delivery participated in this study. Median (interquartile range [IQR]) maternal UIC values were 120 (105-157) and 253 (126-470) μg/L before and after delivery, respectively (p<0.001). No significant correlations were observed between maternal UIC before and after delivery and neonatal thyrotropin levels.

Conclusions: Application of PVP-I significantly increased UIC in postpartum mothers; however, thyrotropin concentration in neonates, whose mothers had adequate UIC, was within the normal range.

Keywords: maternal urinary iodine; neonatal thyrotropin; povidone-iodine.

MeSH terms

  • Adult
  • Anti-Infective Agents, Local / therapeutic use*
  • Congenital Hypothyroidism / blood
  • Congenital Hypothyroidism / diagnosis*
  • Cross-Sectional Studies
  • Delivery, Obstetric / methods*
  • Female
  • Humans
  • Infant, Newborn
  • Iodine / urine*
  • Neonatal Screening
  • Nutritional Status
  • Povidone-Iodine / therapeutic use*
  • Pregnancy
  • Thyrotropin / blood*

Substances

  • Anti-Infective Agents, Local
  • Povidone-Iodine
  • Thyrotropin
  • Iodine